Overview

Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine

Status:
Completed
Trial end date:
2007-05-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is compare efficacy and tolerability of a fixed combination, containing 500 mg Acetylsalicylic acid and 30 mg Pseudoephedrine, in comparison to its single components in patients with sore throat and nasal congestion.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Aspirin
Ephedrine
Pseudoephedrine